Wnt-5a expression in breast carcinomas - Differences between in-situ and invasive disease

被引:0
|
作者
Dhillon, J [1 ]
Walker, RA [1 ]
机构
[1] Univ Leicester, Leicester LE1 7RH, Leics, England
来源
JOURNAL OF PATHOLOGY | 2004年 / 204卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:13A / 13A
页数:1
相关论文
共 50 条
  • [41] Abnormal ezrin expression in invasive breast carcinomas
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 225 - 226
  • [42] The protein expression of nestin in invasive breast carcinomas
    Magkou, C.
    Tampaki, A.
    Theohari, I.
    Tsaldari, E.
    Giannopoulou, I.
    Keramopoulos, A.
    Nakopoulou, L.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 261 - 261
  • [43] DISTRIBUTION OF HSP-27 AND HER-2/NEU IN IN-SITU AND INVASIVE DUCTAL BREAST CARCINOMAS
    STORM, FK
    GILCHRIST, KW
    WARNER, TFCS
    MAHVI, DM
    ANNALS OF SURGICAL ONCOLOGY, 1995, 2 (01) : 43 - 48
  • [44] Analysis of the expression and function of Wnt-5a and Wnt-5b in developing and regenerating axolotl (Ambystoma mexicanum) limbs
    Ghosh, Sukla
    Roy, Stephane
    Seguin, Carl
    Bryant, Susan V.
    Gardiner, David M.
    DEVELOPMENT GROWTH & DIFFERENTIATION, 2008, 50 (04) : 289 - 297
  • [45] Expression of potential biomarkers MCM5 and CDC6 in coexisting in-situ and invasive squamous cell carcinomas of the uterine cervix
    Tovar, M. M.
    Cibull, M. L.
    DeSimone, C. P.
    Karabakhtsian, R. G.
    LABORATORY INVESTIGATION, 2008, 88 : 227A - 227A
  • [46] Expression of potential biomarkers MCM5 and CDC6 in coexisting in-situ and invasive squamous cell carcinomas of the uterine cervix
    Tovar, M. M.
    Cibull, M. L.
    DeSimone, C. P.
    Karabakhtsian, R. G.
    MODERN PATHOLOGY, 2008, 21 : 227A - 227A
  • [47] Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease:: a calibrated aCGH study
    Iakovlev, Vladimir V.
    Arneson, Nona C. R.
    Wong, Vietty
    Wang, Chunjie
    Leung, Stephanie
    Iakovleva, Gaiane
    Warren, Keisha
    Pintilie, Melania
    Done, Susan J.
    CLINICAL CANCER RESEARCH, 2008, 14 (14) : 4446 - 4454
  • [48] Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas
    Gobbi, H
    Arteaga, CL
    Jensen, RA
    Simpson, JF
    Dupont, WD
    Olson, SJ
    Schuyler, PA
    Plummer, WD
    Page, DL
    HISTOPATHOLOGY, 2000, 36 (02) : 168 - 177
  • [49] DIFFERENCES IN QUANTITATIVE NUCLEAR FEATURES BETWEEN DUCTAL CARCINOMA IN-SITU (DCIS) WITH AND WITHOUT ACCOMPANYING INVASIVE-CARCINOMA IN THE SURROUNDING BREAST
    SUSNIK, B
    WORTH, A
    PALCIC, B
    POULIN, N
    LERICHE, J
    ANALYTICAL CELLULAR PATHOLOGY, 1995, 8 (01): : 39 - 52
  • [50] AN EVALUATION OF DIFFERENCES IN PROGNOSIS, RECURRENCE PATTERNS AND RECEPTOR STATUS BETWEEN INVASIVE LOBULAR AND OTHER INVASIVE CARCINOMAS OF THE BREAST
    DUTOIT, RS
    LOCKER, AP
    ELLIS, IO
    ELSTON, CW
    NICHOLSON, RI
    ROBERTSON, JFR
    BLAMEY, RW
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1991, 17 (03): : 251 - 257